(Q51587187)

7 April 2018

reason for preferred rank

title

High-dose fluvastatin and bezafibratecombination treatment for heterozygous familial hypercholesterolemia (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(05)80023-2

9 June 2024

High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604804

9 June 2024

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604804

9 June 2024

author name string

O. Eliav

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604804

9 June 2024

D. Schurr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604804

9 June 2024

P. Pfister

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604804

9 June 2024

Y. Friedlander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604804

9 June 2024

E. Leitersdorf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604804

9 June 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

7 April 2018

13 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7604804

full work available at URL

9 June 2024

https://api.elsevier.com/content/article/PII:S0002914905800232?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(05)80023-2

https://api.elsevier.com/content/article/PII:S0002914905800232?httpAccept=text/plain

9 June 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(05)80023-2

American Journal of Cardiology

9 June 2024

published in

1 reference

7 April 2018

volume

76

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

76A-79A

1 reference

7 April 2018

Combination drug therapy for familial combined hyperlipidemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Clinical pharmacokinetics and practical applications of simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Fluvastatin in familial hypercholesterolemia: a cohort analysis of the response to combination treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980023-2

Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate

7 January 2021

7

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(05)80023-2

Long-term experience with pravastatin in clinical research trials

9 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(05)80023-2

Updated clinical safety experience with fluvastatin

9 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(05)80023-2

9 June 2024

Identifiers

1 reference

7 April 2018

1 reference

7 April 2018